Question 1

How many clinical trials has China National Center for Cardiovascular Diseases sponsored?

Accepted Answer

ClinicalMetric currently tracks 13 clinical trials sponsored by China National Center for Cardiovascular Diseases, of which 13 are actively recruiting participants. These trials cover conditions including Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

Question 2

What therapeutic areas does China National Center for Cardiovascular Diseases research focus on?

Accepted Answer

China National Center for Cardiovascular Diseases is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Coronary Heart Disease.

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Question 3

How do I participate in a China National Center for Cardiovascular Diseases clinical trial?

Accepted Answer

To participate in a China National Center for Cardiovascular Diseases trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all China National Center for Cardiovascular Diseases trials with current recruitment status updated daily.

China National Center for Cardiovascular Diseases

Frequently Asked Questions — China National Center for Cardiovascular Diseases

Clinical Trials by China National Center for Cardiovascular Diseases

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment

QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

Perioperative Cerebral Function Assessment for Cardiac Surgery

Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI.

Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study

LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)

Internal Microstructure of Patent Foramen Ovale Related to Stroke

Natural History of Coronary Atherosclerosis